Shenzhen Pregene Biopharma Co., Ltd. (874090), a national high-tech enterprise with the mission of “Developing urgently needed cell and gene therapy drugs for clinical treatment”, is one of the founders of Guangdong Research Center for Innovative Drug Engineering Technology of Cell and Gene Therapy, and one of Shenzhen Specialized and Sophisticated Enterprises. It has been deeply involved in the field of cell and gene therapy drugs for many years.
Cellular Drug R&D
and Industrialization Platform
IPSC Reprogramming and
Multi-gene Editing Platform
and Multi-gene Editing Platform
Recruitment of CAR-NK
Therapy for multiple myeloma (MM)
Galapagos is a comprehensive biopharmaceutical company with R&D, production and sales capabilities, dedicated to the discovery, development and commercialization of innovative drugs.
Xianbo Biological is committed to bringing innovative cell therapy products to cancer patients.
Dr. Reddy’s Laboratories established in 1984, headquatered in Hyderābād State.
On June 15, the Shenzhen Municipal Bureau of Industry and Information Technology announced the list of "professional,
BEIJING, May 13, 2021 /PRNewswire/ -- Beijing Time May 10, 2021 — Dr. Reddy's Laboratories Ltd. (BSE: 500124,
NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) and...
Shenzhen Pregene Obtained the Clinical Implied License for the Anti-BCMA CAR-T Drug from NMPA with
the Support from Lewwin...
On March 5, 2020, the Department of Science and Technology of Guangdong Province issued the Notice of the Department of
Science and Technology of Guangdong Province on Identifying the Engineering...